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Abstract
Background: We sought to establish the optimal waist circumference (WC) cut-off point for predicting diabetes
mellitus (DM) and to compare the predictive ability of the metabolic syndrome (MetS) criteria of the Joint Interim
Statement (JIS) and the Japanese Committee of the Criteria for MetS (JCCMS) for DM in Japanese.
Methods: Participants of the Japan Epidemiology Collaboration on Occupational Health Study, who were aged
20–69 years and free of DM at baseline (n = 54,980), were followed-up for a maximum of 6 years. Time-dependent
receiver operating characteristic analysis was used to determine the optimal cut-off points of WC for predicting DM.
Time-dependent sensitivity, specificity, and positive and negative predictive values for the prediction of DM were
compared between the JIS and JCCMS MetS criteria.
Results: During 234,926 person-years of follow-up, 3180 individuals developed DM. Receiver operating characteristic
analysis suggested that the most suitable cut-off point of WC for predicting incident DM was 85 cm for men and
80 cm for women. MetS was associated with 3–4 times increased hazard for developing DM in men and 7–9
times in women. Of the MetS criteria tested, the JIS criteria using our proposed WC cut-off points (85 cm for men
and 80 cm for women) had the highest sensitivity (54.5 % for men and 43.5 % for women) for predicting DM.
The sensitivity and specificity of the JCCMS MetS criteria were ~37.7 and 98.9 %, respectively.
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Conclusion: Data from the present large cohort of workers suggest that WC cut-offs of 85 cm for men and
80 cm for women may be appropriate for predicting DM for Japanese. The JIS criteria can detect more people
who later develop DM than does the JCCMS criteria.
Keywords: Waist circumference, Metabolic syndrome, Diabetes mellitus
Background
Metabolic syndrome (MetS) is defined as a clustering of
metabolic abnormalities [1], and has been shown to be
associated with increased risks of developing type 2 dia-
betes mellitus (DM) and cardiovascular disease [2–4].
However, controversy exist over the diagnostic criteria
and utility of MetS [5–7]. Of several MetS criteria pro-
posed [5, 8], the National Cholesterol Education Program
Adult Treatment Panel III (NCEP-ATP III) [1] and the
International Diabetes Federation (IDF) [9] have been most
widely used. In 2009, a Joint Interim Statement (JIS) cri-
teria was published as a combined effort by a number of
international scientific bodies and authorities [8]. Besides
these international definitions, a Japanese-specific MetS
criteria has been proposed by the Japanese Committee of
the Criteria for MetS (JCCMS) [10].
These criteria differ in several aspects, including the
cut-off points of waist circumference (WC), handling of
the WC component (prerequisite or optional for the diag-
nosis of MetS), and the criteria of hyperglycemia and
dyslipidemia. These differences have led to confusion re-
garding the choice of the criteria to diagnose MetS. One
major concern for Japanese individuals is the WC cut-off
point. The JCCMS adopts cut-offs of WC ≥85 cm for men
and ≥90 cm for women [10]. In Japan, cross-sectional
studies have suggested cut-off points of 85–90 cm for
men and 77–83 cm for women for predicting the presence
of multiple other MetS components [11–13], and a recent
prospective study showed that the optimal cut-off point of
WC for predicting cardiovascular disease (CVD) was
90 cm in men and 80 cm in women [14]. Several pro-
spective studies have examined the ethnic specific WC
cut-off values in relation to DM risk among Koreans,
Mexicans, and Americans [15–17]; however, no such
study has yet been performed in the Japanese population.
Here, we examined the optimal WC cut-off points for
predicting the development of DM and compared the
predictive ability of two MetS criteria (JIS [8] and JCCMS
[10]) in a large-scale working population in Japan.
Methods
Survey description
The Japan Epidemiology Collaboration on Occupational
Health (J-ECOH) Study is an ongoing multicenter epide-
miologic study among workers from several companies
in Japan. A total of 12 companies covering various
industries (electric machinery and apparatus manufac-
turing; steel, chemical, gas, and non-ferrous metal
manufacturing; automobile and instrument manufac-
turing; plastic product manufacturing; and health care)
participated in the J-ECOH study. As of May 2014,
eleven participating companies provided health check-
up data obtained between January 2008 and December
2013 or between April 2008 and March 2014. In this
study, the data from the earliest examination (mostly
carried out in 2008) were regarded as the baseline data;
however, if the 2008 dataset contained a large number
of missing data, the data from the 2009 or 2010 (one
company each) examination were used as the baseline.
The outcomes of the present prospective analysis were
determined using data from the health check-ups after
the baseline through 2014.
The J-ECOH Study was announced in each company
using posters. In Japan, workers are obliged to undergo
health examination at least once a year under the Industrial
Safety and Health Act; nearly all workers attend their
health examination in each year. Participants did not pro-
vide their oral or written informed consent to take part in
the study but were given an opportunity to refuse the use
of their data for research, according to the Japanese Ethical
Guidelines for Epidemiological Research [18]. The de-
tails of the J-ECOH Study have been described else-
where [19, 20]. The study protocol was approved by the
Ethics Committee of the National Center for Global
Health and Medicine, Japan.
Study participants
As shown in Fig. 1, of 95,040 participants who attended
the baseline health check-up, we excluded those who
were aged <20 or ≥70 years, who had DM or missing
data necessary for the diagnosis of DM or MetS, and
who attended the health check-up in a non-fasting state
or lacked information on smoking. Of the remaining
58,753 participants, we further excluded those who did not
attend any subsequent health check-up or who attended
but did not receive glucose measurements, leaving 54,980
participants (46,981 men and 7999 women) for analysis.
Measurements
The body height, body weight, WC, and blood pressure
were measured according to a standard protocol of each
company. Body mass index (BMI) was calculated as the
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weight in kilograms divided by the squared height in
meters. WC was measured at the umbilical level using
a measuring tape, with the subjects in the standing pos-
ition [21]. Blood pressure was measured in a sitting
position. Hypertension was defined as systolic blood pres-
sure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, or
as receiving medical treatment for hypertension [22].
Smoking status was ascertained via a self-administered
questionnaire.
The plasma glucose was measured by the enzymatic or
glucose oxidase peroxidative electrode method. Glycated
hemoglobin (HbA1c) was measured by using latex agglutin-
ation immunoassay, high-performance liquid chromatog-
raphy, or the enzymatic method. Total cholesterol (TCH),
triglyceride (TG), low-density lipoprotein-cholesterol
(LDL-C), and high-density lipoprotein-cholesterol (HDL-C)
level were measured by the enzymatic method. All labora-
tories involved in the health checkup in the participating
companies have received satisfactory scores (rank A or
a score >95 out of 100) from external quality control
agencies.
Criteria of MetS
We defined the presence of MetS using the following
two criteria (Table 1): JIS [8] and JCCMS [10].
Outcome
DM was identified using data from the annual health
check-ups for a maximum of 6 years after the baseline
examination. DM was defined as HbA1c ≥6.5 %, fast-
ing plasma glucose ≥126 mg/dl, random plasma glu-
cose ≥200 mg/dl, or currently under medical treatment
for DM, according to the American Diabetes Associ-
ation criteria for the diagnosis of DM [23]. Individuals
without DM at baseline who met any of the above
Fig. 1 Flow chart of participant selection
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conditions in the subsequent check-ups were considered
to have an incident case of type 2 DM.
Statistical analyses
All analyses were performed separately by sex. Descrip-
tive statistics were generated using the sample size,
percentage, and mean. Chi-square tests for categorical
variables or t-tests for continuous variables were used to
examine differences in baseline characteristics between
subjects with incident DM and those who did not develop
it. Age-standardized incidence of DM and mean WC for
each company were calculated by direct standardization to
the total population of the present study. Time-dependent
receiver operating characteristic (ROC) curves for WC for
predicting the development of DM in the next 5 years
were depicted with the Kaplan-Meier method [24]. The
optimal WC cut-offs on the ROC curve were determined
by applying the Youden’s index [25] and the closest top-
left point approaches [26].
Person-time was calculated from the date of the base-
line examination to the date of the first diagnosis of DM
in a subsequent examination or to the date of the last
examination, whichever occurred first. Cox proportional
hazards regression models were used to estimate the
hazard ratios (HRs) for the development of DM associ-
ated with MetS in men and women, respectively. Covari-
ates included age (years) and tobacco smoking (current
smoker, non-current smoker). Company was treated as a
cluster variable to account for intraclass correlations.
The time-on-study was used as the primary time scale.
We verified that the proportional hazards assumption was
not violated for our main exposure and other covariates
by including interaction terms with time, and we used the
Wald chi-square procedure to test whether all coefficients
equaled 0. To compare the predictive ability of the JIS and
the JCCMS MetS criteria, the sensitivities, specificities,
and positive and negative predictive values at 5-year
follow-up were determined [27].
The JCCMS criteria requires WC as a prerequisite for
the diagnosis of MetS [10]. Hence, additional analyses
were performed to determine if the sensitivity and speci-
ficity of JCCMS could be improved when having WC as
an “optional” rather than “essential” criterion (modified
JCCMS criteria).
The time-dependent sensitivities, specificities, and posi-
tive and negative predictive values for different criteria of
MetS were performed using R version 3.2.2 (R Foundation
for Statistical Computing, Vienna, Austria). All other
statistical analyses were performed using SAS version
9.3 (SAS Institute, Cary, NC, USA). A two-sided P <0.05
was considered statistically significant.
Results
During 234,926 person-years of follow-up (a median of
4.9 years), 3180 individuals (2963 men and 217 women)
developed DM. The incidence rate of progression to DM
was 14.7 per 1000 person-years of observation for men,
and 6.5 per 1000 person-years for women. The age-
standardized incidence of DM across companies ranged
between 9 and 15 per 1000 person-years for men, and
between 6 and 7 per 1000 person-years for women.
The baseline characteristics of the subjects according
to the presence or absence of incident DM are shown in
Table 2. For both sexes, the mean age, BMI, WC, systolic
blood pressure, diastolic blood pressure, fasting plasma
glucose, TCH, TG, and LDL-C in subjects who devel-
oped DM were greater than in those who did not, while
the HDL-C was lower. Moreover, the prevalence rates of
hypertension and smoking were higher in subjects with
incident DM than in those who did not develop it for
both men and women. The coefficients between BMI
and WC were 0.88 for men and 0.84 for women. The age-
standardized mean WC across companies ranged between
81.0 and 84.0 cm for men, and between 74.0 and 77.0 cm
for women. The characteristics of the study participants
by MetS and sex are shown in Additional file 1.
Optimal WC cut-off points
Figure 2 shows ROC curves for the prediction of the de-
velopment of DM within the next 5 years using baseline
WC. The AUCs were 0.67 (95 % confidence interval
[CI], 0.61–0.72) for men, and 0.70 (0.62–0.78) for
women. The optimal cut-off points of WC according to
the ROC curve for predicting incident DM for men and
women are shown in Table 3. In men, a cut-off point of
85.0 cm (sensitivity 64.0 %, specificity 59.6 %) yielded
both the maximal Youden index and minimum distance
from the top left corner of the ROC curve. In women, a
cut-off point of 83.0 cm (sensitivity 55.5 %, specificity
79.4 %) yielded the maximal Youden index, and 80.0 cm
Table 1 Diagnostic criteria for metabolic syndrome
Risk factor JIS JCCMS
WC M ≥ 90 Cm W ≥ 80 cm M ≥ 85 cm W ≥ 90 cm
BP SBP ≥ 130 and/or
DBP ≥ 85 mmHg or
on treatment for HPT
SBP ≥ 130 and/or
DBP ≥ 85 mmHg or
on treatment for HPT
FPG ≥100 mg/dl or diagnosed
DM
≥110 mg/dl or diagnosed
DM
TG ≥150 mg/dl or
Treatment for TG
TG ≥150 mg/dl or
treatment for TG or
HDL < 40 mg/dl
HDL-C M < 40 mg/dl, W < 50 mg/dl
or treatment for HDL
Criteria At least 3 WC + 2 or more
WC waist circumference, FPG fasting plasma glucose, TG triglyceride, HDL-C
high-density lipoprotein cholesterol, SBP systolic blood pressure, DBP diastolic
blood pressure, M men, W women, DM diabetes mellitus, HPT hypertension,
Modified NCEP-ATP III National Cholesterol Education Program Adult Treatment
Panel III (2005), JIS the Joint Interim Statement on metabolic syndrome definition
(2009), JCCMS Japanese Committee of the Criteria for Metabolic Syndrome (2005)
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Table 2 Baseline characteristics of subjects
Men Women
No DM DM No DM DM
N 44018 2963 7782 217
Age (years) 45.4 ± 8.9 49.2 ± 7.6* 43.9 ± 8.9 48.4 ± 7.8*
BMI (kg/m2) 23.4 ± 3.0 25.3 ± 3.7* 21.5 ± 3.3 25.3 ± 5.4*
WC (cm) 82.9 ± 8.2 88.0 ± 9.3* 75.4 ± 8.9 84.3 ± 11.8*
FPG (mg/dl) 96.3 ± 8.3 109.2 ± 9.7* 90.8 ± 7.8 104.1 ± 10.2*
TCH (mg/dl)a 200.9 ± 32.6 208.2 ± 33.3* 200.8 ± 33.5 215.7 ± 34.2*
TG (mg/dl) 125.5 ± 90.1 159.7 ± 124.4* 74.9 ± 41.6 121.7 ± 112.7*
LDL-C (mg/dl) 120.2 ± 29.5 126.4 ± 30.5* 113.7 ± 29.9 128.7 ± 32.7*
HDL-C (mg/dl) 57.1 ± 14.4 53.5 ± 13.9* 69.6 ± 15.5 63.4 ± 17.1*
SBP (mmHg) 121.5 ± 14.8 128.1 ± 16.2* 115.3 ± 16.0 127.4 ± 18.3*
DBP (mmHg) 77.1 ± 10.4 81.5 ± 10.7* 71.6 ± 10.6 78.6 ± 11.4*
Hypertension (%) 19.7 36.8* 10.1 31.8*
Smoking (%) 40.5 45.8* 10.7 15.2*
Data was expressed as mean ± SD or as percentages
DM diabetes mellitus, BMI body mass index, WC waist circumference, FPG fasting plasma glucose, TCH Total cholesterol, TG triglyceride, LDL-C low-density lipoprotein
cholesterol, HDL-C high-density lipoprotein cholesterol, SBP systolic blood pressure, DBP diastolic blood pressure
*Difference between groups is statistically significant (P < 0.05)
aData were available for 46,152 subjects
Fig. 2 ROC curves for the prediction of diabetes in the next 5 years using baseline WC. ROC curves showing the ability of baseline waist
circumference (WC) to predict the development of diabetes in the next 5 years
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(62.8 %, 70.7 %) yielded the minimum distance from the
top left corner of the ROC curve. Taken together with
earlier studies in Japan [11–13], we thus propose WC
cut-off points of 85 cm for men and 80 cm for women.
Association between MetS and DM
The prevalence of MetS ranged from 12.0 to 22.1 % in
men and 1.3 to 8.0 % in women according to the different
criteria of MetS (Table 4). The incidence rates of DM were
higher in subjects with MetS than in those without for
both sexes (P < 0.05). In men, the adjusted HRs (95 % CI)
for the development of DM according to the different cri-
teria of MetS were as follows: JIS (Asian WC cut-off value)
3.72 (3.46–4.00), JIS (proposed WC cut-off value) 3.84
(3.69–4.00), and JCCMS (same for Japanese central
obesity criteria and proposed WC cut-off point) 4.16
(3.89–4.45). In women, the adjusted HRs were as follows:
JIS (same for Asian WC cut-off value and proposed WC
cut-off value) 7.08 (6.19–8.09), JCCMS (Japanese central
obesity criteria) 9.63 (8.17–11.36), and JCCMS (proposed
WC cut-off point) 7.40 (5.68–9.64). Kaplan-Meier esti-
mates of DM-free survival by MetS and sex are provided
in Additional file 2.
Sensitivity and specificity
Table 5 shows the sensitivity and specificity for predic-
tion of incident DM in the next 5 years using MetS. In
both sexes, the JIS criteria [8] had a higher sensitivity
than the JCCMS criteria [10]. In men, a large increase in
sensitivity (44.1 to 54.5 %), with only a moderate de-
crease of the positive predictive value (18.5 to 17.1 %),
was seen in the JIS criteria when the WC cut-off point
(90 cm) was substituted by our proposed value (85 cm).
In women, the sensitivity increased (JCCMS, 13.3 to
25.8 %) when the Japanese obesity criteria (WC ≥90 cm)
[10] was substituted by our proposed cut-off point
(80 cm). The specificity for all criteria ranged from 80.6
to 98.9 %. The positive and negative predictive values
were approximately ~28 and 95 %, respectively.
Table 3 Performance of different waist thresholds to predict
the development of diabetes in the next 5 years
Waist thresholds Sensitivity Specificity Youden index Distancea
Men
97.0 cm 16.2 % 94.6 % 0.108 0.840
95.0 cm 18.7 % 93.5 % 0.122 0.816
90.0 cm 35.0 % 83.5 % 0.185 0.671
88.0 cm 49.1 % 73.0 % 0.221 0.576
85.0 cm 64.0 % 59.6 % 0.235 0.541
83.0 cm 68.6 % 54.2 % 0.228 0.555
80.0 cm 81.4 % 38.8 % 0.202 0.640
Women
90.0 cm 29.3 % 94.0 % 0.234 0.709
87.0 cm 38.8 % 90.0 % 0.287 0.621
84.0 cm 50.6 % 84.0 % 0.346 0.519
83.0 cm 55.5 % 79.4 % 0.349 0.490
80.0 cm 62.8 % 70.7 % 0.334 0.474
78.0 cm 64.9 % 67.0 % 0.319 0.482
75.0 cm 75.0 % 54.6 % 0.296 0.518
aDistance, the distance from a point on the curve to the point (0, 1)
Table 4 Risk for the development of diabetes associated with metabolic syndrome
Incidence of diabetes per 1000
person-years
Metabolic syndrome Prevalence at baseline (%) Without With Adjusted HR (95 % CI) for incident DMa
JIS (Asian cut-off points for WC)
Men 16.5 9.7 42.0 3.72 (3.46–4.00)
Women 8.0 4.1 37.1 7.08 (6.19–8.09)
JIS (Proposed cut-off points for WC)
Men 22.1 8.5 38.3 3.84 (3.69–4.00)
Women 8.0 4.1 37.1 7.08 (6.19–8.09)
JCCMS
Men 12.0 10.3 50.2 4.16 (3.89–4.45)
Women 1.3 5.7 72.1 9.63 (8.17–11.36)
JCCMS (Proposed cut-off points for WC)
Men 12.0 10.3 50.2 4.16 (3.89–4.45)
Women 3.4 5.0 53.0 7.40 (5.68–9.64)
DM diabetes mellitus, IDF International Diabetes Federation, JIS the Joint Interim Statement on metabolic syndrome definition, Asian cut-off points for WC waist
circumference ≥90 cm in men or ≥80 cm in women, Proposed cut-off points for WC waist circumference ≥85 cm in men or ≥80 cm in women, JCCMS Japanese
Committee of the Criteria for Metabolic Syndrome
aHRs are adjusted for age and tobacco use
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Additional analyses
When having WC as an “optional” rather than “essential”
criterion (modified JCCMS criteria), the sensitivity
modestly increased from 37.7 to 41.7 % in men and
from 13.3 to 14.2 % in women. The specificity slightly
decreased from 90.0 to 89.7 % in men and from 98.9 to
98.8 % in women.
Discussion
In the present prospective study of a large Japanese
working population, we demonstrated that the optimal
cut-off points of WC for predicting DM were 85 and
80 cm for men and women, respectively. In the compari-
son of the JCCMS criteria, the JIS criteria using the
above WC cut-off points provided the highest sensitivity
for predicting DM. To our knowledge, this is the first
prospective study in Japan to assess the optimal WC
cut-off points for predicting DM and to compare the
predictive abilities of different MetS criteria for the de-
velopment of DM.
In the present study, the incidence rate of DM was
14.7 per 1000 person-years for men and 6.5 per 1000
person-years for women. According to a systematic re-
view and meta-analysis of Japanese studies [28], the inci-
dence rates of DM showed varied considerably among
studies (2.3–52.6 per 1000 person-years). This could be
attributable to differences in background characteristics
(e.g., age and gender), follow-up durations, and diagnos-
tic procedures among studies. In line with the present
findings, previous studies in the Japanese population also
found a higher incidence of DM among men than
among women [29, 30]. For instance, the incidence rate
of DM was 20.9 per 1000 person-years for men and 9.8
per 1000 person-years for women in the Ibaraki Prefec-
tural Health Study (age range: 40–79 years) [29].
Much controversy exist over the current Japanese cut-
offs for WC (85 cm for men and 90 cm for women)
[31], which have been adopted in the JCCMS. The
results of the present ROC analysis indicate that the
optimal cut-off points of WC for predicting the develop-
ment of DM are 85 cm for men and 80 cm for women.
Several studies in the Asian population have reported
that the optimal WC cut-offs for predicting DM were
80–85 cm for men and 75–80 cm for women, based on
cross-sectional data relating WC to the presence of DM
[32–34]. A prospective cohort study in Korea also sug-
gested that WCs of 85 cm for men and 80 cm for
women were appropriate cut-offs to predict the develop-
ment of DM [15]. Taken together, WC cut-off points of
85 cm for men and 80 cm for women may be suitable
for the prediction of development of DM. Besides, a
community-based cohort study in Japan suggested that
the optimal WC cutoff points for predicting CVD were
90 cm for men and 80 cm for women [14]. Further pro-
spective studies are required to confirm whether optimal
cut-off points of WC for predicting DM are different
from those for predicting CVD.
To determine whether, and to what extent, our pro-
posed WC cut-off points (85 cm for men and 80 cm for
women) can improve the performance of the MetS criteria
for predicting DM, we further analyzed the impact of dif-
ferent WC cut-off points on the sensitivity and specificity
of MetS for predicting the development of DM. In
women, the sensitivity of the JCCMS criteria substantially
increased from 13.3 to 25.8 % after substituting the ori-
ginal WC cut-off (90 cm) with our proposed cut-off
(80 cm). Similarly, in men, the sensitivity of the JIS criteria
increased from 44.1 to 54.5 % when the WC cut-off
(90 cm) was substituted by our proposed value (85 cm).
These findings suggest that a MetS criteria using WC
cut-offs of 85 cm for men and 80 cm for women can
identify a greater number of people with increased risks of
DM than the cut-offs for the Asian population (for men)
or the current Japan central obesity criteria (for women).
Several prospective studies outside Japan have investi-
gated the predictability of MetS (defined by IDF, NCEP,
WHO, and the European Group for the Study of Insulin
Resistance) for the development of DM [4]. The Hong
Kong Cardiovascular Risk Factor Prevalence Study showed
that the sensitivity of the modified NCEP-ATP III (similar
to the JIS criteria) tended to be higher compared with the
IDF criteria (41.7 % versus 31.9 %) in the total population
[3]. Further, another study in Beijing, China, also showed
that the sensitivity of the modified NCEP-ATP III was
higher than that of the IDF criteria (52 % versus 44 %)
Table 5 Sensitivity and specificity of JIS and JCCMS criteria for
the prediction of diabetes in the next 5 years
JIS Asian JIS New JCCMS JCCMS new
Sensitivity
Men 44.1 54.5 37.7 37.7
Women 43.5 43.5 13.3 25.8
Specificity
Men 85.7 80.6 90.0 90.0
Women 93.5 93.5 98.9 97.3
PPV
Men 18.5 17.1 21.7 21.7
Women 17.9 17.9 28.2 23.8
NPV
Men 95.4 96.0 95.2 95.2
Women 98.1 98.1 97.2 97.6
JIS the Joint Interim Statement on metabolic syndrome definition, Asian waist
circumference ≥90 cm in men or ≥80 cm in women; New: our proposed waist
circumference ≥85 cm in men or ≥80 cm in women; JCCMS Japanese Committee of
the Criteria for Metabolic Syndrome, PPV positive predictive value, NPV negative
predictive value
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[35]. In our study, the JIS criteria (Asian WC cut-off
values, 44.1 % for men and 43.5 % for women; proposed
cut-off values, 54.5 % for men and 43.5 % for women) was
more sensitive for predicting incident DM than the
JCCMS criteria (Japanese central obesity criteria, 37.7 %
for men and 13.3 % for women; proposed cut-off values,
37.7 % for men and 25.8 % for women), whereas both two
criteria had similar positive predictive values (approxi-
mately ~28 %) and negative predictive values (>95 %).
Therefore, the JIS criteria seems to have superior sensitivity
to predict incident DM in East Asian populations.
Our additional analyses showed only a slight increase
in sensitivity in both sexes when WC was treated as an
optional component of the JCCMS criteria. This finding
suggests that including WC as an “optional” component
in the current JCCMS criteria has minimal impact on its
predictability for DM. One possible explanation is that
WC itself may not be a good risk predictor of DM. In
fact, FPG has much higher ability to identify individuals
with high risk of DM than do other components of the
MetS [3, 36, 37].
Limitations
The main strengths of our study include its prospective
design, large sample size, and sufficient number of DM
events. However, several limitations need to be considered.
First, because the majority of study participants were
employees of large companies, caution should be exercised
in generalizing the present finding to workers in smaller-
sized companies or non-working population. Second, the
sample size for women was relatively small and the
estimates obtained were unstable. Third, the methods of
blood glucose and HbA1c measurements differed among
the companies. Given the highest level of quality control
achieved in all of the participating companies, however,
measurement bias is unlikely. Measurement error is also
inevitable in the assessment of exposures including WC
and blood pressure. Such error usually occurs in random
manner and thus might have attenuated the association.
Fourth, because data on family history of DM and lifestyle
other than smoking (e.g., diet and physical activity) were
not collected in a standardized manner across the partici-
pating companies, we were unable to control for the
effects of these confounders. Lastly, our data are not able
to discriminate between type 1 and type 2 DM. However,
given that the prevalence of type 1 DM is as low as 1.75
per 10,000 in Japanese adults aged 20 years and over [38],
most cases in the present study maybe type 2 DM.
Conclusion
In conclusion, the results of the present study show that
WC cut-offs of 85 cm for men and 80 cm for women
are appropriate for predicting incident DM in the Japanese
population. Use of the JIS criteria detected more cases of
incident DM compared to the JCCMS criteria.
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